Tumor necrosis factor-α and CD40L modulate cell surface morphology and induce aggregation in Ramos Burkitt's lymphoma cells

Leukemia and Lymphoma

Volumn 47, Issue 3, 2006, Pages 507-519

  Laskov, Reuven ^a   Berger, Nir ^a   Scharff, Matthew D ^b   Horwitz, Marshall S ^b  

^a HEBREW UNIVERSITY   (Israel)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

B lymphoma; Filopodia; ICAM 1; Ruffled membrane; Scanning electron microscopy; TNF receptors

Indexed keywords

CD40 LIGAND; CELL ADHESION MOLECULE; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; BURKITT LYMPHOMA; CELL ADHESION; CELL AGGREGATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FILOPODIUM; FLOW CYTOMETRY; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; HUMAN; HUMAN CELL; LYMPHOMA CELL; MICROVILLUS; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; UPREGULATION;

ANTIGENS, CD95; BURKITT LYMPHOMA; CD40 LIGAND; CELL ADHESION; CELL AGGREGATION; CELL LINE, TUMOR; CELL MEMBRANE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 30844435948     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500221454     Document Type: Article

References (64)

1. Van Kooten, C and Banchereau, J. 1996; CD40-CD40 ligand: A multifunctional receptor-ligand pair. Adv Immunol, 61, pp. 1-77.
2. Calderhead, D and Kosaka, Y and Manning, E and Noelle, R. 2000; CD40-CD154 interactions in B-cell signaling. Curr Top Microbiol Immunol, 245, pp. 73-99.
3. Wallach, D and Varfolomeev, E and Malinin, N and Goltsev, Y and Kovalenko, A and Boldin, M. 1999; Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol, 17, pp. 331-367.
4. Renshaw, B and Fanslow, W, III and Armitage, R and Campbell, K and Liggitt, D and Wright, B and 1994; Humoral immune responses in CD40 ligand-deficient mice. J Exp Med, 180, pp. 1889-1900.
5. Allen, R and Armitage, R and Conley, M and Rosenblatt, H and Jenkins, N and Copeland, N and 1993; CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science, 259, pp. 990-993.
6. Durandy, A and Honjo, T. 2001; Human genetic defects in class-switch recombination (hyper-IgM syndromes). Curr Opin Immunol, 13, pp. 543-548.
7. MacLennan, I. 1994; Germinal centers. Annu Rev Immunol, 12, pp. 117-139.
8. Ahonen, C and Manning, E and Erickson, L and O'Connor, B and Lind, E and Pullen, S and 2002; The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells. Nat Immunol, 3, pp. 451-456.
9. Pasparakis, M and Alexopoulou, L and Grell, M and Pfizenmaier, K and Bluethmann, H and Kollias, G. 1997; Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc Natl Acad Sci USA, 94, pp. 6319-6323.
10. Cook, M and Korner, H and Riminton, D and Lemckert, F and Hasbold, J and Amesbury, M and 1998; Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice. J Exp Med, 188, pp. 1503-1510.
11. Ruuls, S and Hoek, R and Ngo, V and McNeil, T and Lucian, L and Janatpour, M and 2001; Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity, 15, pp. 533-543.
12. Kuprash, D and Alimzhanov, M and Tumanov, A and Grivennikov, S and Shakhov, A and Drutskaya, L and (2002) Redundancy in tumor necrosis factor (TNF) and lymphotoxin (LT) signaling in vivo: Mice with inactivation of the entire TNF/LT locus versus single-knockout mice. Mol Cell Biol, 22, pp. 8626-8634.
13. Endres, R and Alimzhanov, M and Plitz, T and Futterer, A and Kosco-Vilbois, M and Nedospasov, S and 1999; Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J Exp Med, 189, pp. 159-168.
14. Denepoux, S and Razanajaona, D and Blanchard, D and Meffre, G and Capra, J and Banchereau, J and 1997; Induction of somatic mutation in a human B cell line in vitro. Immunity, 6, pp. 35-46.
15. Sale, J and Neuberger, M. 1998; TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity, 9, pp. 859-869.
16. Zan, H and Cerutti, A and Dramitinos, P and Schaffer, A and Li, Z and Casali, P. 1999; Induction of Ig somatic hypermutation and class switching in a human monoclonal IgM+ IgD+ B cell line in vitro: definition of the requirements and modalities of hypermutation. J Immunol, 162, pp. 3437-3447.
17. Sutherland, C and Heath, A and Pelech, S and Young, P and Gold, M. 1996; Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J Immunol, 157, pp. 3381-3390.
18. Francis, D and Karras, J and Ke, X and Sen, R and Rothstein, T. 1995; Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int Immunol, 7, pp. 151-161.
19. Grammer, A and Swantek, J and McFarland, R and Miura, Y and Geppert, T and Lipsky, P. 1998; TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells. J Immunol, 161, pp. 1183-1193.
20. Ryffel, B and Brockhaus, M and Durmuller, U and Gudat, F. 1991; Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha. Am J Pathol, 139, pp. 7-15.
21. Gruss, H and Dower, S. 1995; Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood, 85, pp. 3378-3404.
22. Corcione, A and Ottonello, L and Tortolina, G and Tasso, P and Ghiotto, F and Airoldi, I and 1997; Recombinant tumor necrosis factor enhances the locomotion of memory and naive B lymphocytes from human tonsils through the selective engagement of the type II receptor. Blood, 90, pp. 4493-4501.
23. Kehrl, J and Miller, A and Fauci, A. 1987; Effect of tumor necrosis factor alpha on mitogen-activated human B cells. J Exp Med, 166, pp. 786-791.
24. Digel, W and Stefanic, M and Schoniger, W and Buck, C and Raghavachar, A and Frickhofen, N and 1989; Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood, 73, pp. 1242-1246.
25. Buck, C and Digel, W and Schoniger, W and Stefanic, M and Ragnavachar, A and Heimpel, H and 1990; Tumor necrosis factor-alpha, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia. Leukemia, 4, pp. 431-434.
26. Lens, S and Tesselaar, K and den Drijver, B and van Oers, M and van Lier, R. 1996; A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death. J Immunol, 156, pp. 507-514.
27. Aversa, G and Punnonen, J and de Vries, J. 1993; The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J Exp Med, 177, pp. 1575-1585.
28. Yssel, H and Aversa, G and Punnonen, J and Cocks, B and de Vries, J. (1993) Regulation of IgE synthesis by T cells and cytokines. Ann Fr Anesth Reanim, 12, pp. 109-113.
29. Pasparakis, M and Alexopoulou, L and Episkopou, V and Kollias, G. 1996; Immune and inflammatory responses in TNF alpha-deficient mice: A critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med, 184, pp. 1397-1411.
30. Zhang, W and Bardwell, P and Woo, C and Poltoratsky, V and Scharff, M and Martin, A. 2001; Clonal instability of V region hypermutation in the Ramos Burkitt's lymphoma cell line. Int Immunol, 13, pp. 1175-1184.
31. Tweeddale, M and Lim, B and Jamal, N and Robinson, J and Zalcberg, J and Lockwood, G and 1987; The presence of clonogenic cells in high-grade malignant lymphoma: A prognostic factor. Blood, 69, pp. 1307-1314.
32. Gabay, C and Ben-Bassat, H and Schlesinger, M and Laskov, R. 1999; Somatic mutations and intraclonal variations in the rearranged Vkappa genes of B-non-Hodgkin's lymphoma cell lines. Eur J Haematol, 63, pp. 180-191.
33. Gooding, R and Bybee, A and Cooke, F and Little, A and Marsh, S and Coelho, E and 1999; Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia. Br J Haematol, 106, pp. 669-681.
34. Pixley, F and Lee, P and Condeelis, J and Stanley, E. 2001; Protein tyrosine phosphatase phi regulates paxillin tyrosine phosphorylation and mediates colony-stimulating factor 1-induced morphological changes in macrophages. Mol Cell Biol, 21, pp. 1795-1809.
35. Holm, S. 1979; A simple sequentially rejective multiple test procedure. Scand J Statist, 6, pp. 65-70.
36. Inman, G and Allday, M. 2000; Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent. J Immunol, 165, pp. 2500-2510.
37. Polliack, A. 1978; Surface morphology of lymphoreticular cells: Review of data obtained from scanning electron microscopy. Recent Results Cancer Res, 64, pp. 66-93.
38. Mobius, W and Ohno-Iwashita, Y and van Donselaar, E and Oorschot, V and Shimada, Y and Fujimoto, T and 2002; Immunoelectron microscopic localization of cholesterol using biotinylated and non-cytolytic perfringolysin O. J Histochem Cytochem, 50, pp. 43-55.
39. Polliack, A and Nilsson, K and Laskov, R and Biberfeld, P. 1978; Characteristic surface morphology of human and murine myeloma cells: A scanning and transmission electron microscopic study. Br J Haematol, 39, pp. 25-32.
40. Laskov, R and Scharff, M. (1974) Independent synthesis of light and heavy chains: Quantitation of light-chain production by mouse myeloma variants. J Exp Med, 140, pp. 1112-1116.
41. Steinitz, M and Izak, G and Cohen, S and Ehrenfeld, M and Flechner, I. 1980; Continuous production of monoclonal rheumatoid factor by EBV-transformed lymphocytes. Nature, 287, pp. 443-445.
42. Yan, M and Marsters, S and Grewal, I and Wang, H and Ashkenazi, A and Dixit, V. 2000; Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat Immunol, 1, pp. 37-41.
43. Davey, E and Thyberg, J and Conrad, D and Severinson, E. 1998; Regulation of cell morphology in B lymphocytes by IL-4: Evidence for induced cytoskeletal changes. J Immunol, 160, pp. 5366-5373.
44. Butcher, E and Picker, L. 1996; Lymphocyte homing and homeostasis. Science, 272, pp. 60-66.
45. Avigdor, A and Goichberg, P and Shivtiel, S and Dar, A and Peled, A and Samira, S and 2004; CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood, 103, pp. 2981-2989.
46. Cox, D and Chang, P and Zhang, Q and Reddy, P and Bokoch, G and Greenberg, S. 1997; Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes. J Exp Med, 186, pp. 1487-1494.
47. Ohsawa, K and Imai, Y and Kanazawa, H and Sasaki, Y and Kohsaka, S. 2000; Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J Cell Sci, 113(Pt 17), pp. 3073-3084.
48. Marafioti, T and Jones, M and Facchetti, F and Diss, T and Du, M and Isaacson, P and 2003; Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood, 102, pp. 2868-2876.
49. Lee, H and Dempsey, P and Parks, T and Zhu, X and Baltimore, D and Cheng, G. 1999; Specificities of CD40 signaling: Involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation. Proc Natl Acad Sci USA, 96, pp. 1421-1426.
50. Baker, M and Eliopoulos, A and Young, L and Armitage, R and Gregory, C and Gordon, J. 1998; Prolonged phenotypic, functional, and molecular change in group I Burkitt lymphoma cells on short-term exposure to CD40 ligand. Blood, 92, pp. 2830-2843.
51. Uchida, J and Yasui, T and Takaoka-Shichijo, Y and Muraoka, M and Kulwichit, W and Raab-Traub, N and 1999; Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science, 286, pp. 300-303.
52. Dadgostar, H and Cheng, G. 1998; An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-kappaB activation but is dispensable for c-Jun N-terminal kinase signaling. J Biol Chem, 273, pp. 24775-24780.
53. Fruman, D and Snapper, S and Yballe, C and Davidson, L and Yu, J and Alt, F and 1999; Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science, 283, pp. 393-397.
54. Mitchison, T and Cramer, L. 1996; Actin-based cell motility and cell locomotion. Cell, 84, pp. 371-379.
55. Allen, W and Jones, G and Pollard, J and Ridley, A. 1997; Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages. J Cell Sci, 110, pp. 707-720.
56. Croker, B and Tarlinton, D and Cluse, L and Tuxen, A and Light, A and Yang, F and 2002; The Rac2 guanosine triphosphatase regulates B lymphocyte antigen receptor responses and chemotaxis and is required for establishment of B-1a and marginal zone B lymphocytes. J Immunol, 168, pp. 3376-3386.
57. Romanova, L and Alexandrov, I and Blagosklonny, M and Nordan, R and Garfield, S and Acs, P and 1999; Regulation of actin cytoskeleton in lymphocytes: PKC-delta disrupts IL-3-induced membrane ruffles downstream of Rac1. J Cell Physiol, 179, pp. 157-169.
58. Zhang, X and Machii, T and Matsumura, I and Ezoe, S and Kawasaki, A and Tanaka, H and 2003; Constitutively activated Rho guanosine triphosphatases regulate the growth and morphology of hairy cell leukemia cells. Int J Hematol, 77, pp. 263-273.
59. Polliack, A. 2002; Hairy cell leukemia: Biology, clinical diagnosis, unusual manifestations and associated disorders. Rev Clin Exp Hematol, 6, pp. 366-388.
60. Goodman, G and Bethel, K and Saven, A. 2003; Hairy cell leukemia: An update. Curr Opin Hematol, 10, pp. 258-266.
61. Burthem, J and Zuzel, M and Cawley, J. 1997; What is the nature of the hairy cell and why should we be interested? Br J Haematol, 97, pp. 511-514.
62. Goasguen, J and Le Prise, P and Leblay, R and Richier, J. 1983; Adherence properties of hairy cells. Nouv Rev Fr Hematol, 25, pp. 97-102.
63. Jansen, J and Meijer, C and van der Valk, P and de Bruyn, W and Leijh, P and den Ottolander, G and 1979; Phagocytic potential of hairy cells. Scand J Haematol, 23, pp. 69-79.
64. Gibbons, D and Rowe, M and Cope, A and Feldmann, M and Brennan, F. 1994; Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Eur J Immunol, 24, pp. 1879-1885.